A tension system (10) is provided, including first and second tissue anchors (20A, 20B) configured to be anchored to two target sites, respectively; and first and second tethers (24A, 24B), coupled to the first and the second tissue anchors (20A, 20B), respectively. An implantable force gauge (30) includes first and second components (31A, 31B), which are fixed to the first and the second tethers (24A, 24B), respectively, and which are non-integral with each other and are configured to be coupled together in situ so as to couple the first and the second tissue anchors (20A, 20B) together via the first and the second tethers (24A, 24B), for applying variable tension between the two target sites. The implantable force gauge (30) is configured to provide a radiographically-discernible indication of a magnitude of the variable tension between the two target sites, enabling radiographically monitoring of changes in the magnitude of the tension

An expandable structure comprising: a first shape memory (SM) portion which is in a strain-induced state; and a second portion which resists expansion of said structure due to said first portion, over a plurality of different expansion states of said first portion. Optionally, wherein said SM portion resists contraction of said structure due to forces applied by said second portion. Optionally or alternatively, said strain induced state is characterized by a SM portion expanding force decreasing as a function of strain of said SM portion, so as to have a difference of at least 10% in force between two strain states said structure is usable at.

A percutaneous transluminal angioplasty device includes a catheter defining one or more lumens. A filter is coupled to the catheter adjacent a distal end of the catheter, and the filter is movable between an unexpanded and expanded configuration via a filter activation wire that extends through a lumen. An expandable balloon is coupled to the catheter proximally of the filter, and a stent is disposed over at least a portion of the balloon. To deploy the stent to a target site, the filter is first moved into its expanded position via the filter activation wire. Then, the stent is expanded, and the balloon is inflated to expand the stent further radially. The balloon is then deflated, the filter is contracted, and the catheter, balloon, and filter are removed from the body.

A growth stent and valve and methods for making and using the same. The growth stent and valve may be delivered to treat early stage congenital lesions, while expanding to adult vessel diameters. In selected embodiments, the growth stent and valve can comprise a frame and may have a covering on some portion to prevent blood flow through a wall of the frame. The growth stent and valve advantageously can maintain radial strength across an entire range of diameters necessary to treat a narrowed lesion from birth and childhood through adulthood as the vessels grow over the lifetime of a patient.

The stent has an expansive force 0.05 N/mm or less per unit length when it has a diameter equal to the lower limit diameter of the target blood vessel and is measured under the following conditions. A radial force testing system manufactured by Blockwise Engineering LLC is used as a tester. The test conditions include a temperature of 37° C.±2° C. in the chamber of the tester; a stent diameter of 0.5 mm for start of test, and a rate of increase of diameter of 0.5 mm/s in the tester. The test method includes radially compressing the stent disposed in the chamber; recording an expansive force while gradually increasing the diameter of the chamber at the rate of increase of diameter; and dividing the expansive force by the effective length of the stent to calculate an expansive force per unit length.

An implantable expandable medical device in which selected regions of the device are in a martensite phase and selected regions are in an austenite phase. The martensitic regions exhibit pseudoplastic behavior in vivo and may be deformed without recovery under in vivo body conditions. In contrast the austenitic regions exhibit superelastic behavior in vivo and will recover their pre-programmed configuration upon deformation or release of an applied strain.

A stent (1) comprising a tubular frame (2) comprising a first end (3) and a second end and a longitudinal axis (4) therebetween. The frame (2) comprises a plurality of struts (9) defining a generally cylindrical portion comprising a longitudinally extending helical fin (11) protruding radially inwardly and having a helix angle. The angle, relative to the longitudinal axis (4), of at least some of the struts (9) in the helical fin (11) is substantially aligned with the helix angle of the helical fin (11).

A stent for use in hollow tubular organs, comprising a continuous tubular or cylindrical inner cavity which is delimited by a wall. The wall is formed in a tubular or cylindrical manner about an axis which runs in a longitudinal direction and has a structure which surrounds the wall. The structure is made of elements, and the elements are made of loops which are arranged about the longitudinal axis in the radial direction. The elements are rigidly connected via connection points such that a tubular or cylindrical single-piece wall structure is produced, and the stent has acute angles in the region of the connection points.

Thin-film mesh for medical devices and related methods are provided. The thin-film mesh may include slits to be expanded into pores, and the expanded thin-film mesh may be used as a cover for a stent device. The thin-film mesh has a tube-shape and the slits may be angled with respect to a longitudinal axis of the tube-shape thin-film mesh. The angled slits allow for the thin-film mesh to expand in multiple dimensions, including along the longitudinal axis and along the circumferential direction of the tube-shape thin-film mesh. The slits may be provided in diagonal rows arranged in longitudinal columns. Longitudinal columns of different types of slits may be arranged along the circumferential direction on the tube-shape thin-film mesh to form a zig-zag pattern of slits. The thin-film mesh may be formed from thin-film Nitinol (TFN) and may be fabricated via sputter deposition on a micropatterned wafer.

A system for reshaping a valve annulus includes an elongate template having a length along a longitudinal axis and at least one concavity in a generally lateral direction along said length. The pre-shaped template is positioned against at least a region of an inner peripheral wall of the valve annulus, and at least one anchor on the template is advanced into a lateral wall of the valve annulus to reposition at least one segment of the region of the inner peripheral wall of the valve annulus into said concavity. In this way, a peripheral length of the valve annulus can be foreshortened and/or reshaped to improve coaption of the valve leaflets and/or to eliminate or decrease regurgitation of a valve.